HHS Just Opened Temporary Peptide Compounding. Pharmacist and CEO of Precision Medicine Explains What Patients Need to Know

Peptide rules have shifted again and again, from advisory committee votes to a temporary policy HHS released on October 28. Christian Stella, PharmD, CEO and co-founder of Precision Medicine, works with both the medication and the policy, and explains what the change means for patients and providers.